An overview of prevalence, determinants and health outcomes of polypharmacy

View/Open
Khezrian_etal_TADS_An_overview_VOR.pdf (444.0Kb)
Publication date
2020
Author
Metadata
Show full item record
Citation
Khezrian , M , McNeil , C J , Murray , A D & Myint , P K 2020 , ' An overview of prevalence, determinants and health outcomes of polypharmacy ' , Therapeutic Advances in Drug Safety , vol. 11 , pp. 1-10 . https://doi.org/10.1177/2042098620933741
URI
https://hdl.handle.net/2164/14507
DOI
https://doi.org/10.1177/2042098620933741
Rights
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Collections